Alembic informs about outcome of board meeting

07 Aug 2018 Evaluate

Alembic has informed that the Board of Directors of the Company at its meeting held today has approved the Unaudited Financial Results of the Company for the quarter ended on 30th June, 2018. Further, the company has informed about Limited Review Report by Statutory Auditors on Unaudited Financial Results for the quarter ended on 30th June, 2018. The time of commencement of the Board Meeting was 11:30 am and the time of conclusion was 12:25 pm.

The above information is a part of company’s filings submitted to BSE.


Alembic Share Price

100.98 -1.70 (-1.66%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×